Home > List All Publishers > BioInformant Worldwide, L.L.C.

BioInformant Worldwide, L.L.C.

BioInformant is the global leader in stem cell industry data. As a specialty research company, we use technology to track and identify profit opportunities in stem cell markets and provide this data to clients that require stem cell strategies. We advise companies on how to market stem cell products for immediate profit, competitively position products for additional profits within 1-3 months, and approach product development for dramatic long-term profits. Our clients acquire more stem cell customers within 30 days, using the strategies in our reports.

List of reports from BioInformant Worldwide, L.L.C.

Cord Blood Database 2/23/2012 \| published by: BioInformant Worldwide, L.L.C. ... you want to sell to cord blood banks? Do you recognize the huge population of potential clients this market represents? If so, this may be a critical resource for your business. To allow you to ... \| more...	$995.00
Choices In Cord Blood Banking: Factors Influencing Parental Decision-Making 4/1/2009 \| published by: BioInformant Worldwide, L.L.C. ... genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, many expectant parents still do not fully understand the significance of cord blood storage. A study published in the Journal of Reproductive Medicine shows ... \| more... Search inside this report	$3,295.00
Strategic Development of Neural Stem & Progenitor Cell Products 1/1/2012 \| published by: BioInformant Worldwide, L.L.C. ... multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a ... \| more... Search inside this report	$3,495.00
Opportunities in Human Embryonic Stem Cell (hESC) Products 1/1/2010 \| published by: BioInformant Worldwide, L.L.C. ... types and can develop into over 200 different cell types of the human body, providing tremendous therapeutic potential. Human ESCs were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and ... \| more... Search inside this report	$3,495.00
Stem Cell Research Products: Opportunities, Tools, & Technologies 5/1/2012 \| published by: BioInformant Worldwide, L.L.C. ... funded research, rapid changes have been occurring in the field of stem cell science. Not surprisingly, analysis of stem cell publication rates, grant activity, patent applications, and new product launches reveal that stem cell research ... \| more... Search inside this report	$3,495.00
Mesenchymal Stem Cells - Advances & Applications 4/1/2012 \| published by: BioInformant Worldwide, L.L.C. ... most interest is that this rate of growth accelerated in 2011, making mesenchymal stem cells the fastest growing area of stem cell research. Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into ... \| more...	$3,995.00
Capitalizing on Opportunities in Cord Blood Industry Growth 4/1/2012 \| published by: BioInformant Worldwide, L.L.C. ... To guide industry competitors, this report considers the questions: What factors are causing a substantial number of new cord blood banks to open up business? What will be the effect of these new entrants to ... \| more...	$3,995.00